Jan Aushadhi Diwas 2026: How India's Generic Drug Drive Is Saving Lives

Access to affordable medicines remains one of the biggest challenges in healthcare systems worldwide, especially in low- and middle-income countries. In India, where a significant portion of medical expenses is paid directly by households, the cost of medicines can be a major financial burden. To address this, the Government of India launched the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP), a programme designed to provide high-quality generic medicines at significantly lower prices.

Every year on March 7, the country observes Jan Aushadhi Diwas, a campaign aimed at raising awareness about the benefits of generic medicines and encouraging people to use them. The initiative highlights the role of Jan Aushadhi Kendras, special pharmacies set up across India that sell affordable medicines for common diseases such as diabetes, hypertension, infections, and cardiovascular conditions.

Over the past decade, the scheme has expanded rapidly and become a key component of India's strategy to improve healthcare affordability. By reducing the cost of medicines, often the largest component of out-of-pocket health spending, the programme aims to make treatment more accessible to millions of people.

What Is Jan Aushadhi Diwas?

Jan Aushadhi Diwas is an annual public awareness campaign organised by India's Department of Pharmaceuticals under the Ministry of Chemicals and Fertilisers. The campaign promotes the use of generic medicines and educates the public about their safety, effectiveness, and affordability. The campaign is closely linked to the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP), launched to ensure that quality medicines are available at affordable prices. Under this scheme, special pharmacies known as Jan Aushadhi Kendras are opened across the country to distribute generic medicines and essential medical products.

Events during Jan Aushadhi Diwas typically include health camps, awareness drives, and outreach programmes designed to increase public understanding of generic medicines and expand access to affordable treatment.

How The Jan Aushadhi Scheme Works

The PMBJP programme focuses on making generic medicines widely available through a network of government-supported retail outlets. These stores procure medicines through centralised tenders and supply them nationwide via a structured logistics system.

Key features of the scheme include:

• Low-cost generic medicines: Products are typically priced 50-90% lower than branded alternatives.
• Extensive product basket: Over 2,047 medicines and around 300 surgical products are available through the programme.
• Wide disease coverage: Medicines span major therapeutic categories such as antibiotics, cardiovascular drugs, diabetes medicines, anti-cancer drugs, and gastrointestinal treatments.

Generic medicines contain the same active ingredients as branded medicines and are required to meet the same quality and safety standards set by regulatory authorities. The government also emphasises quality control. Medicines supplied through Jan Aushadhi Kendras are sourced from WHO-GMP compliant manufacturers and tested in government-approved laboratories before distribution.

Rapid Expansion Across India

The reach of Jan Aushadhi Kendras has grown dramatically in recent years. As of late 2025, nearly 18,000 Kendras were operational across India, and the government aims to expand the network to 25,000 outlets by 2027. This rapid expansion is intended to ensure that affordable medicines are accessible even in remote and rural areas. In many states, these outlets are being integrated into district hospitals and community health centres to improve accessibility for patients. According to government data, these pharmacies collectively serve over 10 lakh people every day, demonstrating the scale of the initiative's impact.

Why Affordable Medicines Matter In India

One of the biggest reasons the Jan Aushadhi campaign matters is the high level of out-of-pocket healthcare spending in India. Research shows that medicines account for a large share of healthcare expenses for Indian households. Lowering the cost of medicines can therefore significantly reduce financial stress and improve treatment adherence.

Studies from global health organisations such as the World Health Organization have repeatedly highlighted that improving access to affordable medicines is a key strategy for achieving universal health coverage. When medicines are affordable, patients are more likely to follow prescribed treatment, which can reduce complications and hospitalisation. The availability of low-cost medicines is particularly important for chronic conditions such as diabetes, hypertension, and heart disease- conditions that require lifelong treatment.

Economic Impact Of The Scheme

Beyond improving access to treatment, the Jan Aushadhi initiative has also generated significant financial savings for patients. Government estimates suggest that the programme has helped citizens save around Rs.30,000 crore on medicines since its expansion. For many families, these savings can make a substantial difference. Chronic illnesses often require multiple medications taken daily, and cheaper alternatives can reduce long-term healthcare costs significantly. The scheme also supports entrepreneurship. Jan Aushadhi Kendras are often run by pharmacists, NGOs, and small business owners, creating livelihood opportunities while expanding access to affordable medicines.

Changing Public Perception Of Generic Medicines

Despite their benefits, generic medicines have historically faced skepticism in India, largely due to concerns about quality or effectiveness. However, health authorities and global medical bodies emphasise that approved generics are therapeutically equivalent to branded medicines. According to the World Health Organization, generic medicines are required to demonstrate the same safety, quality, and efficacy as the original branded drugs once patent protections expire. Public awareness campaigns like Jan Aushadhi Diwas aim to address misconceptions and encourage patients and doctors to consider generics as a safe and cost-effective option.

Jan Aushadhi Diwas 2026 underscores a broader shift in India's healthcare policy: making essential medicines accessible and affordable for all citizens. Through the expansion of Jan Aushadhi Kendras and the promotion of generic medicines, the government has taken significant steps toward reducing healthcare costs and improving treatment access. While challenges remain, including awareness gaps and supply consistency, the programme's rapid growth and measurable cost savings demonstrate its potential. As India continues to expand the initiative, Jan Aushadhi Diwas serves as a reminder that affordable medicines are not just a policy goal but a crucial component of equitable healthcare.

Disclaimer: This content including advice provides generic information only. It is in no way a substitute for a qualified medical opinion. Always consult a specialist or your own doctor for more information. NDTV does not claim responsibility for this information.